Alison Kodjak

Alison Fitzgerald Kodjak is a health policy correspondent on NPR's Science Desk.

Her work focuses on the business and politics of health care and how those forces flow through to the general public. Her stories about drug prices, limits on insurance and changes in Medicare and Medicaid appear on NPR's shows and in the Shots blog.

She joined NPR in September 2015 after a nearly two-decade career in print journalism, where she won several awards—including three George Polk Awards—as an economics, finance, and investigative reporter.

She spent two years at the Center for Public Integrity, leading projects in financial, telecom, and political reporting. Her first project at the Center, "After the Meltdown," was honored with the 2014 Polk Award for business reporting and the Society of Professional Journalists Sigma Delta Chi award.

Her work as both reporter and editor on the foreclosure crisis in Florida, on Warren Buffet's predatory mobile home businesses, and on the telecom industry were honored by several journalism organizations. She was part of the International Consortium of Investigative Journalists team that won the 2015 Polk Award for revealing offshore banking practices.

Prior to joining the Center, Alison spent more than a decade at Bloomberg News, where she wrote about the convergence of politics, government, and economics. She interviewed chairmen of the Federal Reserve and traveled the world with two U.S. Treasury secretaries.

And as part of Bloomberg's investigative team she wrote about the bankruptcy of General Motors Corp. and the 2010 Gulf Oil Spill. She was part of a team at Bloomberg that successfully sued the Federal Reserve to release records of the 2008 bank bailouts, an effort that was honored with the 2009 George Polk Award. Her work on the international food price crisis in 2008 won her the Overseas Press Club's Malcolm Forbes Award.

Fitzgerald Kodjak and co-author Stanley Reed are authors of In Too Deep: BP and the Drilling Race that Took It Down, published in 2011 by John Wiley & Sons.

She's a graduate of Georgetown University and Northwestern University's Medill School of Journalism.

She raises children and chickens in suburban Maryland.

Consumers don't need to use antibacterial soaps, and some of them may even be dangerous, the Food and Drug Administration says.

On Friday, the FDA issued a rule banning the use of triclosan, triclocarban and 17 other chemicals in hand and body washes. which are marketed as being more effective than simple soap.

Copyright 2016 NPR. To see more, visit NPR.

The U.S. could rein in rising drug prices by being more selective about giving patents to pharmaceutical companies for marginal developments, a study concludes.

That's because brand-name drugs with patents that grant exclusivity account for about 72 percent of drug spending, even though they are only about 10 percent of all prescriptions dispensed, according to the study, published Tuesday in JAMA, the journal of the American Medical Association.

Copycat versions of biotech drugs work just as well as the originals and cost a lot less, according to an analysis of studies of the medicines.

The analysis by researchers at Johns Hopkins Bloomberg School of Public Health finds that so-called biosimilars — medications that are meant to mimic, and compete with, complex and expensive biotech drugs — perform as well as the brand-name versions.

Copyright 2016 NPR. To see more, visit http://www.npr.org/.

Lisa Lynn Kotnik has been a singer on the New Orleans club circuit for more than 15 years.

"I sang at Fritzel's for eight years," she says. "I sang at the Bombay Club for 15 years, I sang at Margaritaville — the list could go on and on and on."

While Kotnik sings to revelers at night under the stage name Lisa Lynn, in the daytime she's battled health problems — fibroids, ovarian cysts, a hysterectomy and even a brain aneurysm.

The first time Ray Tamasi got hit up by an investor, it was kind of out of the blue.

"This guy called me up," says Tamasi, president of Gosnold on Cape Cod, an addiction treatment center with seven sites in Massachusetts.

"The guy" represented a group of investors; Tamasi declines to say whom. But they were looking to buy addiction treatment centers like Gosnold.

Hillary Clinton is floating a proposal to let people over the age of 50 "buy in" to Medicare, the federal government's health insurance for those 65 and older.

The Democratic presidential contender mentioned the idea earlier this week at a campaign event in Stone Ridge, Va. She was responding to a woman who said her health insurance premiums — which she bought on the individual market — rose more than $500 last year.

"What you're saying is one of the real worries that we're facing with the cost of health insurance," Clinton said. "The costs are going up in many markets."

The Food and Drug Administration is banning the sale of electronic cigarettes to minors as part of a broad set of regulations the agency finalized Wednesday.

With the rules that were more than two years in the making, the agency is expanding its authority over e-cigarettes, cigars and hookah tobacco, in much the same way it already regulates traditional cigarettes.

When the health insurance premiums got to the point that they were higher than her mortgage, Renee Powell started to become cynical.

"There was something in me that just kind of switched," said the mother of two from Bartlesville, Okla. "I was OK with paying $750, but when it became about $100 more than my housing costs, it upset me."

Powell is an epidemiologist and used to work for the state in Oklahoma City. She had affordable insurance through that job.

Pages